The patient was a 68-year-old woman with breast cancer (17 mm grade III invasive ductal carcinoma, ER 15%, PR 0%, HER2 IHC 2+ [but ISH–], Ki-67 35%). This evidence concerns the gene ERBB2 and breast carcinoma.